Mergers and acquisitions – Page 17

Business
Pfizer reshuffle hints at future split decision

2013-07-31T00:00:00Z

Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
Business
Perrigo bags Elan and its bargain Irish tax rates

2013-07-31T00:00:00Z

$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
Business
Thousands face job cuts after Valeant's Bausch buyout

2013-07-30T00:00:00Z

Valeant plans to shed 10-15% of its workforce to save $800 million
Business
Aspen in $1 billion deal with Merck & Co

2013-07-01T00:00:00Z

South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
Business
AstraZeneca stocks pipeline with acquisitions

2013-06-10T00:00:00Z

Spending spree continues with two more deals
Business
Bayer buys Conceptus for $1.1bn

2013-04-29T00:00:00Z

Deal gives German pharma giant access to surgery-free permanent birth control procedure
Business
Thermo Fisher to buy Life Technologies in $15.8bn deal

2013-04-19T00:00:00Z

Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
Business
Dispute over Arkema finances

2013-03-13T00:00:00Z

French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
Business
OM Group to exit cobalt business

2013-01-24T00:00:00Z

Deal worth up to $435 million includes downstream activities, in particular cobalt refining in Kokkola, Finland
Business
BASF ups Pronova bid

2013-01-16T00:00:00Z

Pronova BioPharma specialises in omega-3 fatty acids
Business
Illumina investment push

2013-01-08T00:00:00Z

$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
Feature
2012 chemical industry review

2013-01-04T00:00:00Z

It was a mixed year for the sector
Business
Clariant sells business bundle for CHF500m

2013-01-03T00:00:00Z

Textile, paper and emulsion businesses to go to US investment firm
Business
2012 pharma industry roundup

2013-01-03T00:00:00Z

What were the bigger stories? And how did the industry fare overall?